Albert N Ngo

Open door policy or email appointment

ADV Pharmaceutics III & PHA 6180 PHA 4107 Drug Delivery III  M, W, F - 9:00 a.m – 9:50 a.m.
ADV Pharmaceutics I & PHA 3102 Drug Delivery I T, Th - 1:00 p.m-1:50 p.m. and Fr. 12:00 p.m-12:50 p.m
Pharmaceutics I (PHA 3110) M, W, F - 1:00 p.m.-1:50 p.m
Pharmaceutical Sciences Concepts I M&W 11:15 a.m-1:00 p.m.

---

---

Dr. Ngo received his B.S. degree in chemical engineering from the National Polytechnic Institute Felix Houphouët-Boigny-Yamoussoukro, Cote d’Ivoire in 2008 and his Ph.D. degree in pharmaceutics and drug design from the University of Missouri-Kansas City, Missouri, United States, in 2018. Dr. Ngo published his research work in prestigious academic platforms such as Pharmaceutical Research, IJP, etc. He is the inventor of two United States patents. In July 2023, Dr. Ngo joined FAMU-COPPS,IPH, as an Assistant Professor of Pharmaceutics. His research interest is developing “smart” nanoparticles (SSFNs), targeting PSMA for prostate cancer therapy.

---

---

• Drug Discovery and Translational Research
  
• Nanotheranostics
  
• Nanoparticle Drug delivery system
  
• Pharmacogenomic
  
• Material Science
  

---

---

---

---

• Post-Doctoral Associate- 7/2018-12/2018.
  University of Missouri-Kansas City, Kansas City, MO
• Assistant Professor of Pharmaceutical Science (Full time). 2019-2023
  American University of Health Sciences, Signal Hill, CA
• Clinical Assistant Professor (Part-time), 2019-2023
  Charles R. Drew University of Medicine and Science, Los Angeles, CA
• Assistant Professor of Pharmaceutical Science 2023-Present
  Florida A&M University, Tallahassee, FL

---

---

•  Ngo AN; Yang S; Wu Y; Schloss J, Vadgama J. Engineering of Layer-By-Layer Smart Acetate Coated Paclitaxel Loaded Polylactic-Co-Glycolic Acid Nanoparticles to Treat Prostate Cancer RCMI and ACS diversity in Cancer research Abstract, 2023
  
  
• Ngo AN, Murowchick J; Gounevc AD, Gounev TK; Youan C.B a, *, "Physico-Chemistry and Cytotoxicity of Tenofovir Loaded Acid Phosphatase Responsive Chitosan Nanoparticles," AAPS Pharmscitech ( 2023)
  
•  Inventors: Ngo NA, Bi-Botti C. Youan Formulations For Pharmaceutical Agents
  U.S. Patent App. No. 16/847,960, Issued date, 12/20/2022
  https://patentcenter.uspto.gov/applications/16847960
  
  
• go, A.N., Islam, M.A., Aoyagi, J. et al. Prevalence of Hypertension in Homeless Adults: An Interprofessional Education Community-Based Health Fairs Cross-Sectional Study in Urban Long Beach, California. High Blood Press Cardiovasc Prev 28, 63–68 (2021). https://doi.org/10.1007/s40292-020-00424-8
  
•  Inventors; Ngo NA, Bi-Botti C. Youan; Preparation of acetate Salt composition of Pharmaceutical Agents US Patent#15/178938, Issued date, 02/26/2019
  https://patentcenter.uspto.gov/applications/15178938
  
  
• Ngo AN, David Turbow; Principal Component Analysis of Morbidity and Mortality among the United States Homeless Population: A Systematic Review and Meta-Analysis., Int Arch Public Health Community Med 2019, 3:025.
  
  
• Ngo AN, Engineering of Human Acid Phosphatase Enzyme Sensitive Nanomedicine for HIV/AIDS Prevention by Topical Route, University of Missouri Kansas City, 2018. https://mospace.umsystem.edu/xmlui/handle/10355/68861
  
  
• Ngo AN.; Thomas, D.; Murowchick, J.; Ayon, N. J.; Jaiswal, A.; Youan, B. C., Engineering fast dissolving sodium acetate mediated crystalline solid dispersion of docetaxel. Int J Pharm 2018, 545 (1-2), 329-341.
  
  
• Ngo AN, Ezoulin MJ, Murowchick JB, Gounev AD, & Youan BB (2016) Sodium Acetate Coated Tenofovir-Loaded Chitosan Nanoparticles for Improved Physico-Chemical Properties. Pharm Res 33(2):367-383
  
  
•  Ngo AN, Ezoulin MJ, Youm I, & Youan BB (2014) Optimal Concentration of 2,2,2-Trichloroacetic Acid for Protein Precipitation Based on Response Surface Methodology. J Anal Bioanal Tech 5(4).
  

---

---

• FAMU Albert Nguessan Ngo (PI) 10/2023-06/2024 125,000 USD
  PI start-up
  
  
• CDU DCRT/ACS Albert Nguessan Ngo (PI) 5/2022-5/2023 30,000 USD
  
  
• CDU Division of Cancer Research and Training (DCRT) and American Cancer Society (ACS) Award for a project titled Development of 'Smart' Acetate-Coated Nanoparticles to Treat Prostate Cancer.

---

---

•  PPHA 4107 Drug Delivery III
  
• PHA6180_301_2238 Adv Pharmaceutics I
  
• PHA6182_301_2238, Adv Pharmaceutics III
  
• PHA3102_301_2238 Drug Delivery I
  
• PHA4107_301_2238 Drug Delivery III
  
• PHA6517_301_2238 Pharm Concepts Grads
  
• PHA3110_301_2238 Pharmaceutics I
  

---

---

• Google Scholar

• LinkedIn